Importance Substance use disorders (SUDs) represent a pressing public health concern.
Combined behavioral and pharmacological interventions are considered best practices for …

In the setting of liver cirrhosis (LC), profound hemostatic changes occur, which affect primary
hemostasis, coagulation, and fibrinolysis. They involve prohemorrhagic and prothrombotic …

Conclusions Most Veterans with cirrhosis and coexisting AUD did not receive behavioral
therapy or pharmacotherapy treatment for AUD over a 6‐month follow‐up. The reductions in …

Abstract Alcohol Use Disorder (AUD) has a disconcertingly high relapse rate (70–80%
within a year following withdrawal). Preventing relapse or minimizing its extent is hence a …

Aim The purpose of this brief narrative review is to address the complexities and benefits of
extending animal alcohol addiction research to the human domain, emphasizing Allostasis …

Aims Sustained heavy alcohol consumption is associated with a range of neurocognitive
deficits. Yet, past research centers on a severe profile of alcohol use disorder (AUD), with …

The mineralocorticoid receptor (MR) is an emerging target in the field of alcohol research.
The MR is a steroid receptor in the same family as the glucocorticoid receptor, with which it …

Objective: Using electronic health record (EHR) data from a systematic, primary care–based
alcohol screening, brief intervention, and referral to treatment (SBIRT) initiative within a …

Background: Emerging evidence suggests that opioid receptor antagonists, such as
naltrexone, are effective pharmacotherapies for alcohol, opioid, and possibly stimulant use …

Abstract Purpose of Review This paper provides a narrative review of studies published over
the past 5 years that have examined the role of affect, including both affective symptoms and …